Simcyp Limited Releases Virtual Chinese Patient Population as China Increases Its Dominance in the World Pharmaceutical Market  
1/9/2012 9:26:08 AM

SHEFFIELD, England--(BUSINESS WIRE)--With China poised to become the world’s third largest market for pharmaceuticals, Simcyp Limited today announces the addition of a virtual Chinese patient population to the portfolio of virtual human populations within the Simcyp Simulator – the industry’s most sophisticated tool for the simulation of drug-drug interactions and pharmacokinetic outcomes.